Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

EHA/ESMO clinical practice guidelines for the management of malignant lymphoma: recommendations for the second phase of the COVID-19 pandemic (CROSBI ID 309507)

Prilog u časopisu | pregledni rad (stručni) | međunarodna recenzija

Dreyling, Martin ; Aurer, Igor ; Federico, Massimo ; Jerkeman, Mats ; Kersten, Marie Jose ; Linton, Kim ; Mey, Ulrich ; Tilly, Herve ; Buske, Christian EHA/ESMO clinical practice guidelines for the management of malignant lymphoma: recommendations for the second phase of the COVID-19 pandemic // HemaSphere, 5 (2021), 2; e529-e531. doi: 10.1097/HS9.0000000000000529

Podaci o odgovornosti

Dreyling, Martin ; Aurer, Igor ; Federico, Massimo ; Jerkeman, Mats ; Kersten, Marie Jose ; Linton, Kim ; Mey, Ulrich ; Tilly, Herve ; Buske, Christian

engleski

EHA/ESMO clinical practice guidelines for the management of malignant lymphoma: recommendations for the second phase of the COVID-19 pandemic

Recommendations for the Second Phase of the COVID-19 Pandemic in Clinical Practice Guidelines for the Management of Malignant Lymphoma

lymphoma ; COVID19

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

5 (2)

2021.

e529-e531

objavljeno

2572-9241

10.1097/HS9.0000000000000529

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost